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Ⅰ. INTRODUCTION 
Tooth avulsion constitutes 0.5-16% of all traumatic
injuries in permanent anterior teeth1). Successful re-
plantation of an avulsed tooth may depend on the
presence of viable cells in periodontal ligament,
which can proliferate on denuded root surface2,3).
Therefore, in case of the periodontal injury by tooth
avulsion, maintenance of viable periodontal ligament
fibroblasts (PDLFs) would be one of the most impor-
tant factors for the good prognosis.
During extra alveolar period, storage medium could
be used not only to preserve the PDLFs, but also to
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stimulate their growth. Polypeptide growth factors
are a class of natural biological mediators that regu-
late the proliferation, differentiation, migration, and
matrix synthesis of cells4). The growth factors studied
for proliferation and wound healing nowadays are
epidermal growth factor (EGF), platelet-derived
growth factor (PDGF), transforming growth factor
(TGF) and insulin-like growth factors (IGF I & II).
Recently, it has been reported that polypeptide
growth factors enhanced the formation of bone,
dentin, and collagen fibers in periodontal wounds5).
Lynch et al. demonstrated that short-term applica-
tion of a combination of PDGF-B and IGF could en-
hance the formation of periodontal attachment appa-
ratus by 5-10 folds during the early phase of wound
healing after surgery6). Therefore, growth factors
could be used as a locally acting therapeutic agent to
preserve and regenerate PDLFs after avulsive dental
injury. 
EGF is the first tissue-derived peptide enhancing
proliferation and differentiation of cells. EGF was ex-
tracted from submaxillary glands, and induced preco-
cious tooth eruption and premature eyelid opening
when injected into newborn animals7). In human,
most of circulating EGF is associated with blood
platelets, synthesized by megakaryocytes, and re-
leased in the process of blood coagulation. Locally
EGF is also secreted from parotid and submandibular
glands, and released directly into saliva8).
Hormones systemically regulate growth and metab-
olism of body whereas growth factors locally take ef-
fect on tissue. In the developing animal and human,
thyroid hormones play a critical role in development
and differentiation of tissues and organs9,10). Also, ex-
ogenous tri-iodothyronine (T3) injection raised the
turnover rate of cells in the periodontal ligament is
well known that T3 interact with other hormones
such as growth hormones and steroid hormones11). 
Heparin-binding epidermal growth factor-like
growth factor (HB-EGF) was first identified as a 20-
22 KD glycoprotein in conditioned medium of
macrophage-like cells12). Similar to other EGF-family
growth factors, HB-EGF binds to the epidermal
growth factor receptor (EGFR), thereby inducing its
phosphorylation and stimulates DNA synthesis in
target cells13). HB-EGF plays an important role in
myogenesis, mucosal repair of stomach, protecting
the small bowl from ischemic injury, pancreatic de-
velopment, vascular remodeling, renal cell repair and
proliferation, liver regeneration and wound healing14).
The purpose of this study was to evaluate the ef-
fect of EGF alone and combination with T3 or HB-
EGF on the proliferation of PDLFs and the effect of
EGF on the wound healing and therefore to evaluate
EGF for a candidate of therapeutical application of
for the preservation and regeneration of PDLFs in a
traumatically avulsed tooth. 
Ⅱ. MATERIALS AND METHODS
1. Experimental materials
1) EGF
Easyf� (Daewoong Pharm Co. Ltd. Korea) was dis-
solved with 10% phosphate buffered saline (PBS) to
a concentration of 10-6 g/ml for the stock solution. It
was then diluted in PBS to several appropriate con-
centrations just before the experiment.
2) T3
T3 (Sigma-Aldrich Co) was dissolved in 1 N NaOH
to a concentration of 1 mg/ml. It was diluted with
10% phosphate buffered saline (PBS) makin g 10-5 M
stock solution and stored at -20℃. It was further di-
luted to several appropriate concentrations just be-
fore experiment.
3) HB-EGF
HB-EGF(R & D Co.) was dissolved with 10% PBS
to a concentration of 5 ㎍/ml for the stock solution
and stored at -20℃. It was then diluted to several
appropriate concentrations for the experiment.
4) Periodontal ligament fibroblasts (PDLFs)
Human PDLFs were obtained and cultured from
the explant tissue of human healthy periodontal liga-
ment taken from several first premolars that were
extracted for orthodontic reasons.
2. Experimental methods
1) Cell culture
After removing calculus and plaque in mouth, the
premolar was extracted and rinsed 3 times with
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Hanks’balanced salt solution (HBSS) to remove the
blood clot of root surface. The periodontal ligament
tissues from the middle third of the roots were
minced, put in culture dishes and incubated in α-
MEM with 10% fetal bovine serum (FBS) and an-
tibiotics of 100 mg/ml streptomycin, 0.5 mg/ml am-
photericin-B, and 100 unit/ml penicillin at 37 ℃ in a
humidified atmosphere of 5% CO2-95% air. The me-
dia was changed every 3 days until dense single lay-
er was gained. After cells reached confluence, they
were trypsinized with 0.25% trypsin-EDTA in PBS
for subculture. All the experiments were done within
5-10 cellular passages.
2) Bioassay of EGF
3-(4,5-dimethyl-thiazole-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) assay, was used to evaluate
the viable cell proliferation. MTT assay is based on
the principle of tetrazolium salt being reduced by mi-
tochondrial reducing enzyme (succinate dehydroge-
nase) so that the toxicity of viable cells and cellular
differentiations could be evaluated. The reduced
tetrazolium salt is converted into colored water-in-
soluble formazan salt, and it can be evaluated spec-
trophotometrically once the MTT-formazan is dis-
solved in an organic solvent. About 2000 PDLFs
were seeded and grown on the 96 well plate in 200 ㎕
α-MEM/2% FBS for 1day. EGF was diluted to sever-
al appropriate concentrations just before experiment.
Then the culture media was replaced with 200 ㎕ α-
MEM containing EGF at 0.1, 0.5, 1, 10 and 100
ng/ml. Cell proliferation was measured by MTT as-
say after 3 days and 5 days of culture period. 50 ㎕
of MTT solution (5mg/ml) was added per well then
incubated at 37 ℃ in incubator for 4 hrs. The purple
formazan product was dissolved in 150 ㎕ of di-
methylsulfoxide (DMSO) and incubated for 30 min-
utes at 37 ℃ in CO2 incubator. Optical density was
measured on an ELISA reader at 570 nm. 
3) In Vitro Wound Healing Assay
Human PDL cells were grown to confluence on 12-
well tissue culture plates. The cells were then
starved in serum-free α-MEM overnight. The mono-
layer was scratch-wounded with yellow tip. After be-
ing washed once with PBS, the cells were refeded
with serum-free α-MEM in the presence of EGF.
Wound healing was photographed at 24 hr after the
wounding scratch using Olympus CKX41(Olympus,
Japan) inverted microscope system. 
4) Bioassay of mixture (EGF, T3 and HB-EGF)
EGF, T3 and HB-EGF was diluted to several ap-
propriate concentrations just before experiment. The
MTT assay was proceeded as described above 2).
Combination of factors with several concentrations is
listed in Table 1.
5) RT-PCR 
About 6×105 PDLFs were plated on 100×15mm
(100π) dishes in α-MEM/2% FBS and were incubated
overnight to allow attachment prior to the addition of
T3. After 24hrs of incubation period, α-MEM solu-
tions containing (a) 0.1 nM T3, (b) 10 nM T3 were
replaced in experimental group and were replaced in
control group with same media without T3. After 1
day of incubation, cells of 2 groups were harvested
by Trizol. And then DNA was removed with chloro-
form and salted out with isopropanol and 70%
ethanol. After centrifuging, mRNA pellet was dried
then dissolved in diethyl pyrocarbonate (DEPC) wa-
ter. They were stored at -70℃. After mRNA was
quantified by spectrophotometry, cDNA was synthe-
sized by reverse trascriptase with oligo dT primer.
cDNA was used as a template for PCR to amplify the
specific product. The sequences of each set of primers
Table 1. The groups of combination of EGF with T3 or HB-EGF
Group Combinations
Group 1 0.01, 0.1 and 1 ng/ml EGF + 0.1 nM T3 
Group 2 0.01, 0.1 and 1 ng/ml EGF + 10 nM T3 
Group 3 0.01, 0.1 and 1 ng/ml EGF + 0.1 nM HB-EGF 
Group 4 0.01, 0.1 and 1 ng/ml EGF + 0.01 nM HB-EGF 
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are listed below: 
EGFR P1, 5’-ATGCGACCCTCCGGGACGGCCG-3’
EGFR P2, 5’-CCTTCAGTCCGGTTTTATTTGC-3’
PCR was proceeded with AccuPower� RT PreMIX
tube. RT-PCR products were separated by 1%
agarose gel electrophoresis in 0.5% tris-acetate
(TAE) buffer and stained with ethidium bromide. All
data were quantitated relative to β-actin genes. Data
analysis was performed with Spot Denso Analysis of
Frog 2000 software (Alpha Innotech, San Leandro,
CA, USA) .
6) Statistical analysis
Statistical analysis was done with statistical soft-
ware (SAS version 8.1). Absorbance of each concen-
tration was tested by the analysis of Tukey’s multi-
ple comparison tests at 95% confidence level.
Ⅲ. RESULT
1. Effect of EGF on PDLFs proliferation
The purpose of this study was to evaluate the ef-
fect of EGF on the proliferation of PDLFs. In the
treatment of EGF, there was different cellular prolif-
eration between control and 10 ng/ml ; control and
100 ng/ml on the 3rd day with statistical significance
(p<0.05). In addition, the proliferation of PDLFs in
10 ng/ml EGF on the 3rd day was increased up to
32.3% when compared with control, and the prolifer-
ation of PDLFs in 10 ng/ml EGF on the 5th day was
increased up to 41.3% when compared with control
(Fig. 1). The MTT assay suggested that maximum
cellular proliferation was reached at the concentra-
tions of 10 ng/ml EGF on the 3rd and the 5th day.
2. Effect of EGF on PDLFs wound healing
The wound healing effect of EGF was determined
by in vitro wound healing assay to measure the abili-
ty of PDLFs migration to close the wounded gap. A
scratch wound in PDLFs was more closed in the
presence of 10 ng/ml EGF, suggesting that EGF pro-
motes the wound healing of PDLFs (Fig. 2). 
3. Effects of combination of EGF with T3 or HB-
EGF on PDLFs proliferation
In this study, the effects of combination of EGF
with T3 or HB-EGF on PDLFs proliferation were
Fig. 2. Healing of scratch wound in cultured PDL cells. PDL cells seeded on 12-well
plates. After reaching confluence, the cells were starved with serum free α-MEM overnight
and injured with yellow tip. Cells were incubated in serum free α-MEM for 24h, in serum
free α-MEM containing EGF. A; no treatment (control cells), B; 10 ng/ml EGF.
Fig. 1. The proliferation of PDLFs with several EGF
concentrations.
A B
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evaluated by MTT assay. The combination of EGF at
three different concentrations (0.01, 0.1 and 1
ng/ml) with 0.1 nM T3 on the 5th day, showed higher
value of MTT assay than that treated with EGF
alone (Fig. 3). However, there was no statistical sig-
nificance. The proliferation of PDLFs was increased
more in the group of combination compared with the
single treatment. 
The combination of 10 nM T3, and EGF at every
concentration on the 3rd and the 5th day, showed
higher value of MTT assay than that treated with
EGF alone (Fig. 4). The proliferation of PDLFs was
increased dose-dependently in the group of combined
treatment, except for the 1 ng/ml EGF on the 5th
day.
The combination of 0.01 nM HB-EGF and EGF at
every concentration on the 5th day, showed higher
value of MTT assay than that treated with EGF
alone (Fig. 5). The proliferation of PDLFs was in-
creased dose-dependently in the combined treatment,
except for 0.1 nM HB-EGF on the 5th day.
The proliferation of PDLFs was increased in the
group of combination compared with the single treat-
ment. The combination of 0.1 nM HB-EGF and EGF
at every concentration on the 5th day, showed higher
value of MTT assay than that treated with EGF
alone (Fig. 6). The proliferation of PDLFs was in-
creased dose-dependently in the combined treatment
on the 5th day. 
3. RT-PCR
Using RT-PCR, it was tested if the addition of T3
had an effect on mRNA expression of endogenous
Fig. 3. The proliferation of PDLFs with the combination
of 0.1 nM T3 and several different concentrations of
EGF. 
Fig. 4. The proliferation of PDLFs with the combination
of 10 nM T3 and several different concentrations of
EGF.
Fig. 5. The proliferation of PDLFs with the combina-
tion of 0.01 nM HB-EGF and several different
concentrations of EGF.
Fig. 6. The proliferation of PDLFs with the combination




EGFR in PDLFs (Fig. 7). 
All results were analyzed as relative units and
standardized to the amount of β-actin mRNA. In the
treatment of 0.1 nM T3, EGFR expression was in-
creased up to 5.6 folds and in the case of 10 nM T3,
EGFR expression was increased up to 2.5 folds when
compared with control (Table 2). Therefore, T3 en-
hanced the expression amount of EGFR.
Ⅳ. DISCUSSION
Periodontal ligament is a dense connective tissue
between root cementum and alveolar bone that an-
chors the tooth and maintains the structural integri-
ty of mineralized tissues15). Fibroblasts in the peri-
odontal ligament have multipotential heterogenous
ability that can differentiate into either cemento-
blasts or osteoblasts16). An avulsion may cause the
damage of attachment apparatus in periodontal liga-
ment. Thus it is important to maintain the viable
cell of periodontal ligament attached to the avulsed
tooth for the successful replantation. Ideally, the
tooth should be taken good care immediately after
the injury in an effort to preserve the viability of
PDLFs, and thereby to optimize healing process and
minimize root resorption. Therefore, the storage con-
ditions should be designed to maximize preservation
of PDLFs during the transportation to dental office
when immediate replantation of an avulsed tooth is
impossible.
The optimal storage medium should be able to pre-
serve the viability, mitogenicity and clogenic capacity
of injured PDLFs and their progenitors. Numerous
studies have shown that storage conditions and types
of storage media affect the viability of PDLFs.
Recently, three media have been introduced to pre-
serve avulsed teeth : Hanks’Balanced Salt Solution
(HBSS), Viaspan, and fibroblast culture media (α-
MEM)17). Because of the limitation of available con-
ventional storage media to obtain successful regener-
ation of injured PDL tissues, the application of
growth factors have been attempted in clinical use to
accelerate the proliferation of regeneration of PDLFs,
which may locally help tissue repair.
Thyroid hormone modulates the transduction of
signals from several cytokines and growth factors in
human cell lines. Also, thyroid hormone enhances
the effects of EGF on mitogen activated protein ki-
nase (MAPK) activation18,19). And the effect of EGF
on immediate-early gene expression was enhanced by
thyroid hormone. Physiologic levels of thyroid hor-
mone may enhance the autocrine/paracrine effects of
EGF on cells19). 
In this study, the effects of EGF alone and the
synergic effect of EGF with T3 or HB-EGF on the
proliferation of PDLFs and the effect of EGF on the
wound healing were examined to evaluate the poten-
tial application of EGF as a storage media or a pre-
replantation conditioner of avulsed tooth. Cell prolif-
eration of PDLFs was increased dose-dependently in
the presence of EGF up to a concentration of 10
ng/ml. Therefore, the optimal concentration of EGF
Fig. 7. The expression amount of EGFR using RT-PCR.




Table 2. The ratio of EGFR between control and experimental group
EGFR / b-actin (ratio of area) Experimental group / control group
Control 0.157 1
0.1 nM T3 0.877 5.6
10 nM T3 0.394 2.5
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in the cellular growth was reached at 10 ng/ml. It
suggested that EGF could be a Good candidate for a
therapeutic application.
In the group 1 and 2, the combination of EGF with
T 3 or HB-EGF on the 5th day, showed increased val-
ue of MTT assay compared with the group of EGF
alone in spite of the low concentration (Fig. 3-6).
The positive synergic effect of EGF with T3 or HB-
EGF may make EGF better candidate for the thera-
peutic application. Since EGF and HB-EGF bind to
EGF receptor, the synergic effect for these growth
factors may be due to more growth factors available
for EGF receptor of PDLFs. In case of synergic effect
of EGF and T3, it has been reported that T3 modu-
lates EGF-induced renal proximal tubule cell prolif-
eration by an effect on the EGF receptorng/ml20). The
study concluded that T3 enhanced EGF receptor
gene expression increasing the number of cell surface
EGF receptors on renal proximal tubule cells.
Therefore, in this study, using RT-PCR, we tested if
the addition of T3 have an effect on mRNA expres-
sion of endogenous EGFR in PDLFs. As a result, T3
enhanced the expression of EGFR in PDLFs and it
may explain the synergic effect of T3 and EGF. 
From this study we could conclude that EGF could
be used as a pretreatment agent for traumatically
avulsed teeth. Further study is needed to find out
the relationship between these specific growth factors
and matrix synthesis by PDLFs. Also, we need to
proceed in vivo experiment using EGF and the com-
bination with T3 and HB-EGF.
Ⅴ. CONCLUSION 
This study evaluated the effect of EGF alone and
combination with T3 or HB-EGF on the proliferation
of PDLFs by MTT assay and the effect of EGF on the
wound healing by wound healing assay. To under-
stand the synergic effect of EGF with T3, RT-PCR on
EGF receptor was done considering the influence of
T3 on EGF receptor expression. 
The results are summarized as;
1. The cell proliferation of PDLFs was increased
dose-dependently in the presence of EGF
2. The optimal concentration of EGF in cellular
growth was found at the concentrations of 10
ng/ml.
3. EGF promoted the wound healing of PDLFs.
4. The combination of EGF with T3 enhanced the
proliferation of PDLFs.
5. The combination of EGF with HB-EGF also en-
hanced the proliferation of PDLFs.
6. The expression of EGFR was increased with the
treatment of T3.
REFERENCES
1. Andreasen JO : Etiology and pathogenesis of
traumatic dental injuries. A clinical study of
1298 cases. Scan J Dent Res, 78:329-342, 1970.
2. Andreasen JO, Hjo/rting-Hansen E : Replantation
of teeth. I. Radiographic and clinical study of 110
human teeth replanted after accidental loss. Acta
Odontol Scand , 24:263-286, 1966.
3. Andreasen JO, Reinholtd J, Riis I, et al. :
Periodontal and pulpal healing of monkey in-
cisors preserved in tissue culture before replanta-
tion. Int J Oral Surg, 7:104-112, 1978.
4. Terranova VP, Wikesjo UME : Extracellular ma-
trices and polypeptide growth factors as media-
tors of functions of cells of the periodontium. J
Periodontal , 58:371-380, 1987.
5. Giannobile WV : Periodontal tissue engineering
by growth factors. Bone, 19:23S-37S, 1996.
6. Lynch SE, de Castilla GR, Williams RC, et al. :
The effect of short term application of a combina-
tion of platelet-derived and insulin-liked growth
factors on periodontal wound healing. J
Periodontol, 62:458-467, 1991.
7. Cohen S : Isolation of a mouse submaxillary
gland protein accelerating incisor eruption and
eyelid opening in the newborn animal. J Biol
Chem, 237:1555, 1962.
8. Malttila AL, Perheentupa J, Salmi J : Human
epidermal growth factor concentrations in urine
but not in saliva and serum, depend on thyroid
state. Life Sci, 41:2739-2747, 1987.
9. Jannini EA, Ulisse S, D’Armiento M : Thyroid
hormone and male gonadal function. Endor Rev,
16: 443-459, 1995.
10. Jannini EA, Crescenzi A, Rucci N, et al. :
Ontogenic pattern of thyroid hormone receptor




11. KIM SO : The effect of thyroid hormone on the
cell proliferation of periodontal ligament in rat.
Yonsei University, Seoul, 2003.
12. Higashimaya S, Abraham JA, Miller JC, et al. :
A heparin-binding growth factor secreted by
macrophage like cells that is related to EGF.
Science, 251:936-939, 1991.
13. Rabb G, Klagsbrun M : Heparin-binding EGF-
like growth factor. Biochem Biophys Acta,
1333:179-199, 1997. 
14. Karen M, Gail E : Structure and function of
Heparin-binding EGF-like growth factor.
Bioscience d288-d299, 1998. 
15. Angelo M, David L : Characterization of fibrob-
lasts derived from human periodontal ligament
and gingiva. J Periodontol, 61:103-111, 1990.
16. Aukhil MA, Simpson DM : In vitro differentiation
of progenitor cells of periodontal ligament: an ex-
perimental study using physical barriers. J Clin
Periodontol, 13:862-868, 1986.
17. Ashkenaz M, Marouni M, Sarnat H : In vitro vi-
ability, mitogenicity and clonogenic capacity of
periodontal ligament cells after storage in four
media at room temperature. Endod Dent
Traumatol, 16:63-70, 2000.
18. Lekic P, Kenny D, Moe HK, et al. : Relationship
of clonogenic capacity to plating efficiency and vi-
tal dye staining of human periodontal ligament
cells: implications for tooth replantation. J
Periodont Res, 31(4):294-300, 1996.
19. Lin H-Y, Davis FB, Gordinier : Thyroid hormone
induces activation of mitogen-activated protein
kinase in cultured cells. Am J Physiol, 276:
C1014-C1024, 1999.
20. Humes HD, Cieslinski DA, Johnson LB, et al. :
Tri-iodothyronine enhances renal tubule cell
replication by stimulating EGF receptor gene ex-
pression. Am J Physiol, 262:F540-5, 1992. 
J Korean Acad Pediatr Dent 34(3) 2007
446
국문초록
EGF, T3, HB-EGF 가 치주인대섬유모세포에 미치는 영향
홍은경�∙차정헌�∙김연태*∙최병재�∙김성오�
연세대학교 치과대학 소아치과학교실�, 구강생물학교실�, 
연세대학교 구강과학연구소, 대웅생명과학연구소*
치주인대섬유모세포들은 완전탈구 된 치아의 성공적인 재식을 위한 중요한 요소이다. 따라서, 외상으로 인해 완전탈구
된 치아의 보존을 위한 보관액을 선택하는 것이 중요하다. 성장인자들과 호르몬들은 치주인대섬유모세포들의 생존을 위
한 치료적 제제로 고려되고 있다. Epidermal growth factor(EGF)는 다른 조직에서 재생과 상처 치유 과정의 중요한
역할인자로 대두되고 있다. 따라서, 완전탈구 된 치아를 위한 치료적 적용을 위해 EGF의 세포 증식에 미치는 영향을 평
가하였다. 또한 EGF와 tri-iodothyronine(T3)의 혼합액, EGF와 Heparin-binding epidermal growth factor-like
growth factor(HB-EGF)의 혼합액이 세포 증식에 미치는 상승 효과를 평가하였다.
치주인대섬유모세포의 세포증식은 EGF 농도가 증가함에 따라 증가하였고, 10 ng/ml 농도에서 최대 세포증식을 보
였다. EGF는 상처치유분석에서 상처 치유촉진과 이동성을 보여주었다. EGF에 T3와 HB-EGF를 첨가한 혼합액에서
배양한 세포는 EGF만 처리한 경우보다 세포 증식이 상승되었다. EGF와 T3 혼합액의 상승효과 기전을 유추하기 위해
서 RT-PCR로 EGF 수용기의 발현을 확인하였고, T3가 EGF 수용기 발현을 증가시켰음을 확인하였다. 따라서 EGF
와, EGF와 T3, EGF와 HB-EGF의 혼합액은 완전탈구된 치아의 치료에 있어 유용한 선택이 될 것이다. 
주요어 : Epidermal growth factor, Tri-iodothyronine, Heparin-binding epidermal growth factor-like
growth factor, 주인대섬유모세포, 완전탈구
